Search
Now showing items 1-1 of 1
Exploring biomarkers from the tumour and the microenvironment in Diffuse Large B-cell Lymphoma.
(Queen Mary University of London, 2014-11)
In the last decade unprecedented improvement in cure rates and overall survival was achieved in diffuse large B-cell Lymphoma (DLBCL) through the introduction of rituximab and anthracyclin-based chemotherapy (R-CHOP) as ...